{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:12:52Z","timestamp":1778649172330,"version":"3.51.4"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Advanced gastric cancer with negative PD-L1 combined positive score (CPS) responds poorly to immunotherapy. This study investigated the efficacy of hyperthermia combined with a PD-1 inhibitor and chemotherapy in this patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, 72 patients with PD-L1 CPS-negative advanced gastric cancer were enrolled. 37 received hyperthermia plus PD-1 inhibitor and SOX chemotherapy, while 35 received PD-1 inhibitor and chemotherapy alone. Propensity score matching (PSM) was applied. Progression-free survival (PFS) was the primary endpoint. Adverse events and circulating tumor cell dynamics were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After PSM, baseline characteristics were well-balanced. The CIH group showed significantly prolonged PFS compared to the CI group, both before and after matching (P\u00a0=\u00a00.00037 and P\u00a0=\u00a00.0011, respectively). The CIH group also had a significantly lower incidence of fatigue and anorexia (P&amp;lt;0.05). Although circulating tumor cell (CTC) counts increased in both groups after treatment, the post-treatment count and the magnitude of increase were significantly greater in the CIH group (P&amp;lt;0.001), potentially indicating enhanced therapy-induced immune activation and tumor cell death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The addition of hyperthermia to PD-1 inhibitor and chemotherapy significantly improves PFS and reduces specific adverse events in patients with PD-L1 CPS-negative advanced GC. This distinct CTC dynamic change, although still requiring further verification, may offer a potential mechanistic insight into the significant efficacy of this combined strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1795363","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:46:05Z","timestamp":1778647565000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperthermia enhances the efficacy of PD-1 inhibitor plus chemotherapy in PD-L1 CPS-negative advanced gastric cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Weihang","family":"Li","sequence":"first","affiliation":[{"name":"Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[{"name":"Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]},{"name":"Department of Integrated Traditional Chinese and Western Medicine, Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]},{"name":"Department of Integrated Traditional Chinese and Western Medicine, Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]},{"name":"Department of Integrated Traditional Chinese and Western Medicine, Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panling","family":"Xu","sequence":"additional","affiliation":[{"name":"Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]},{"name":"Department of Integrated Traditional Chinese and Western Medicine, Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102805","article-title":"A transformer-based deep learning model for early prediction of lymph node metastasis in locally advanced gastric cancer after neoadjuvant chemotherapy using pretreatment CT images","volume":"75","author":"Zheng","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104837","article-title":"Recent advances in tumour microenvironment impact immunotherapy resistance in gastric cancer","volume":"215","author":"Sun","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuchi.2024.101604","article-title":"Complications following laser interstitial thermal therapy: a review","volume":"71","author":"McGrath","year":"2025","journal-title":"Neurochirurgie"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1487296","article-title":"From cold to hot: mechanisms of hyperthermia in modulating tumor immunology for enhanced immunotherapy","volume":"16","author":"Abreu","year":"2025","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41420-024-01880-0","article-title":"Frontier knowledge and future directions of programmed cell death in clear cell renal cell carcinoma","volume":"10","author":"Fei","year":"2024","journal-title":"Cell Death Discov"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.148111","article-title":"Hyperthermia inhibits the progression of gastric cancer by downregulating PLEK2\/PD-L1 and possibly participates in immunomodulation","volume":"898","author":"Li","year":"2024","journal-title":"Gene"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00717-y","article-title":"Thermal immuno-nanomedicine in cancer","volume":"20","author":"Yang","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705361","article-title":"Immunogenic cell death induction by ionizing radiation","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2013.59","article-title":"TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells","volume":"11","author":"Fang","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2023.2168554","article-title":"Genetic and epigenetic regulation of the innate immune response to gout","volume":"52","author":"de Lima","year":"2023","journal-title":"Immunol Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051394","article-title":"From localized mild hyperthermia to improved tumor oxygenation: physiological mechanisms critically involved in oncologic thermo-radio-immunotherapy","volume":"15","author":"Vaupel","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1039\/d4tb02319f","article-title":"Synergistic microwave hyperthermia treatment for subcutaneous deep in situ breast cancer using conformal array antennas and a microwave-thermal-sensitive nanomaterial","volume":"13","author":"Zhang","year":"2025","journal-title":"J Mater Chem B"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.1466","article-title":"1400O Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G\/GEJ adenocarcinoma","volume":"35","author":"Janjigian","year":"2024","journal-title":"Ann Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12923","article-title":"Extracellular heat shock protein 70 levels in tumour-bearing dogs and cats treated with radiation therapy and hyperthermia","volume":"21","author":"Nytko","year":"2023","journal-title":"Vet Comp Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030625","article-title":"Clinical evidence for thermometric parameters to guide hyperthermia treatment","volume":"14","author":"Ademaj","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1728724","article-title":"The clinical significance of hyperthermic intraperitoneal chemotherapy combined with PD-1 inhibitor and systemic chemotherapy for advanced gastric cancer patients with peritoneal metastasis: a single-center retrospective study","volume":"15","author":"Ren","year":"2025","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.21037\/tlcr-23-144","article-title":"Immunotherapy for advanced non-small cell lung cancer with negative programmed death-ligand 1 expression: a literature review","volume":"13","author":"Bai","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-22-644","article-title":"Intratumoral CD8(+) T cells as a potential positive predictor of chemoimmunotherapy response in PD-L1-negative advanced gastric cancer patients: a retrospective cohort study","volume":"13","author":"Tong","year":"2022","journal-title":"J Gastrointest Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.32604\/or.2025.069832","article-title":"Prognostic value of circulating tumor cells and cancer associated macrophage-like cells in metastatic non-small cell lung cancer patients: a retrospective exploratory analysis","volume":"34","author":"Siringo","year":"2026","journal-title":"Oncol Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1591359","article-title":"Unveiling the dual role of circulating tumor cells in colorectal cancer immunotherapy: a comprehensive review of biomarker utility and immune microenvironment crosstalk","volume":"16","author":"Feng","year":"2025","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1512543","article-title":"Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically 'cold' tumor models","volume":"15","author":"Kennedy","year":"2024","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s417238","article-title":"The incidence and management of cancer-related anorexia during treatment with vascular endothelial growth factor receptor-tyrosine kinase inhibitors","volume":"15","author":"Takahashi","year":"2023","journal-title":"Cancer Manag Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1795363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:46:08Z","timestamp":1778647568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1795363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2026.1795363"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1795363","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1795363"}}